Press Release: Sanofi completes acquisition of Inhibrx, Inc.
Sanofi completes acquisition of Inhibrx, Inc.…
35,940$
3,22%
Echtzeit-Aktienkurs Inhibrx Biosciences Inc.
Bid:
Ask:
Nachrichten zur Inhibrx Biosciences Inc. Aktie
Inhibrx, Inc. (INBX) Reports Q4 Loss, Tops Revenue Estimates
Inhibrx, Inc. (INBX) delivered earnings and revenue surprises of -61.68% and 1,534%, respectively, for the quarter ended December 2023. Do…